Free Trial

Xenon Pharmaceuticals (XENE) Earnings Date, Estimates & Call Transcripts

Xenon Pharmaceuticals logo
$40.29 +0.95 (+2.41%)
(As of 12:50 PM ET)

Xenon Pharmaceuticals Latest Earnings Summary

Upcoming Q4
Earnings Date
Mar. 6Estimated
Actual EPS
(Nov. 12)
-$0.81 Beat By $0.01
Consensus EPS
(Nov. 12)
-$0.82

Xenon Pharmaceuticals announced Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.81, which topped analysts' consensus estimates of -$0.82 by $0.01. With a trailing EPS of -$2.82, Xenon Pharmaceuticals' earnings are expected to decrease next year, from ($3.12) to ($3.75) per share.

XENE Upcoming Earnings

Xenon Pharmaceuticals' next earnings date is estimated for Thursday, March 6, 2025, based off prior year's reporting schedules.

Get Xenon Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Xenon Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

XENE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

XENE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Xenon Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.82-$0.76-$0.79
Q2 20242-$0.85-$0.79-$0.82
Q3 20243-$0.88-$0.80-$0.83
Q4 20244-$0.92-$0.83-$0.88
FY 202411-$3.47-$3.18-$3.32
Q1 20252-$0.88-$0.84-$0.86
Q2 20252-$0.89-$0.85-$0.87
Q3 20252-$0.90-$0.86-$0.88
Q4 20252-$0.91-$0.88-$0.90
FY 20258($3.58)($3.43)($3.51)

Xenon Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/6/2025
(Estimated)
------- 
11/12/2024Q3 2024-$0.82-$0.81+$0.01-$0.81--    
8/8/2024Q2 2024-$0.70-$0.75 -$0.05-$0.75--      
5/9/2024Q1 2024-$0.69-$0.62+$0.07-$0.62-$1.00M      
2/29/2024Q4 2023-$0.76-$0.64+$0.12-$0.64$2.30M-      
11/8/2023Q3 2023-$0.75-$0.73+$0.02-$0.73$1.56M-      
8/9/2023Q2 2023-$0.69-$0.72 -$0.03-$0.72$0.46M-      
When it comes to NVDA… “acceleration cycles” are the key (Ad)

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!
5/9/2023Q1 2023-$0.62-$0.63 -$0.01-$0.63$0.53M-      
3/1/2023Q4 2022-$0.58-$0.57+$0.01-$0.57$2.46M-      

Xenon Pharmaceuticals Earnings - Frequently Asked Questions

Xenon Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates. Learn more on XENE's earnings history.

In the previous quarter, Xenon Pharmaceuticals (NASDAQ:XENE) reported ($0.81) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.82) by $0.01. Learn more on analysts' earnings estimate vs. XENE's actual earnings.

The conference call for Xenon Pharmaceuticals's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Xenon Pharmaceuticals's latest earnings report can be read online.
Read Transcript

Xenon Pharmaceuticals (NASDAQ:XENE) has a recorded annual revenue of $9.43 million.

Xenon Pharmaceuticals (NASDAQ:XENE) has a recorded net income of -$182.39 million. XENE has generated -$2.82 earnings per share over the last four quarters.

Xenon Pharmaceuticals's earnings are expected to decrease from ($3.12) per share to ($3.75) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:XENE) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners